{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:05:37Z","timestamp":1772809537393,"version":"3.50.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.urology.2008.10.005","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T13:02:27Z","timestamp":1229518947000},"page":"S25-S35","source":"Crossref","is-referenced-by-count":43,"special_numbering":"S","title":["Conventional Treatments of Localized Prostate Cancer"],"prefix":"10.1016","volume":"72","author":[{"given":"Marc","family":"Zerbib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Zelefsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celestia S.","family":"Higano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2008.10.005_bib1","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1200\/JCO.2004.10.062","article-title":"The changing face of low-risk prostate cancer: trends in clinical presentation and primary management","volume":"22","author":"Cooperberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2008.10.005_bib2","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1097\/01.ju.0000091641.34674.11","article-title":"Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE","volume":"170","author":"Harlan","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.20.2.557","article-title":"Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer","volume":"20","author":"Wei","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2008.10.005_bib4","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/01.ju.0000141712.79986.77","article-title":"Active surveillance with selective delayed intervention: using natural history to guide treatment in good risk prostate cancer","volume":"172","author":"Klotz","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0022-5347(05)65271-8","article-title":"Expectant management of nonpalpable prostate cancer with curative intent: preliminary results","volume":"167","author":"Carter","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib6","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.juro.2007.08.039","article-title":"Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience","volume":"178","author":"Carter","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib7","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1097\/01.ju.0000118224.54949.78","article-title":"An analysis of men with clinically localized prostate cancer who deferred definitive therapy","volume":"171","author":"Patel","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib8","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.juro.2007.08.072","article-title":"Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities","volume":"178","author":"Eggener","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1464-410x.2000.00405.x","article-title":"A comparison of the relative merits of radical perineal and radical retropubic prostatectomy","volume":"85","author":"Sullivan","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2008.10.005_bib10","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0022-5347(05)67512-X","article-title":"Laparoscopic radical prostatectomy: the Montsouris technique","volume":"163","author":"Guillonneau","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.urolonc.2007.05.020","article-title":"Laparoscopic radical prostatectomy: contemporary comparison with open surgery","volume":"25","author":"Romero-Otero","year":"2007","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2008.10.005_bib12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/01.ju.0000153486.94741.e5","article-title":"Laparoscopic radical prostatectomy with the Heilbronn technique: oncological results in the first 500 patients","volume":"173","author":"Rassweiler","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.juro.2006.10.070","article-title":"Comparison of length of hospital stay between radical retropubic prostatectomy and robotic assisted laparoscopic prostatectomy","volume":"177","author":"Nelson","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib14","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/01.ju.0000169455.25510.ff","article-title":"Robotic assisted laparoscopic radical prostatectomy versus retropubic radical prostatectomy: a prospective assessment of postoperative pain","volume":"174","author":"Webster","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib15","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMsa011788","article-title":"Variations in morbidity after radical prostatectomy","volume":"346","author":"Begg","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2008.10.005_bib16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/jnci\/djm060","article-title":"The surgical learning curve for prostate cancer control after radical prostatectomy","volume":"99","author":"Vickers","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2008.10.005_bib17","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/00000478-199312000-00006","article-title":"The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer","volume":"17","author":"Ohori","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urology.2008.10.005_bib18","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/cncr.21895","article-title":"Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy","volume":"106","author":"Secin","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2008.10.005_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.eursup.2005.01.003","article-title":"How to preserve continence after radical prostatectomy","volume":"4","author":"Ravery","year":"2005","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.urology.2008.10.005_bib20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0094-0143(05)70163-4","article-title":"Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience","volume":"28","author":"Han","year":"2001","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.urology.2008.10.005_bib21","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/01.ju.0000134888.22332.bb","article-title":"Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results","volume":"172","author":"Roehl","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.urology.2005.06.116","article-title":"Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (\u201ctrifecta\u201d)","volume":"66","author":"Bianco","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.10.005_bib23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.urology.2007.03.042","article-title":"Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005","volume":"69","author":"Makarov","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.10.005_bib24","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1097\/01.ju.0000091100.83725.51","article-title":"Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens","volume":"170","author":"Eastham","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib25","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0022-5347(01)62543-6","article-title":"Radical prostatectomy for prostate cancer: the perineal approach increases the risk of surgically induced positive margins and capsular incisions","volume":"160","author":"Boccon-Gibod","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib26","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1200\/JCO.2006.10.4067","article-title":"Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911","volume":"25","author":"van der Kwast","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2008.10.005_bib27","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1200\/JCO.2006.08.9607","article-title":"Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy","volume":"25","author":"Stephenson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2008.10.005_bib28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-5347(05)63946-8","article-title":"Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer","volume":"169","author":"Han","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib29","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/01.ju.0000107260.98031.0e","article-title":"Is year of radical prostatectomy a predictor of outcome in prostate cancer?","volume":"171","author":"Cagiannos","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.urology.2005.06.084","article-title":"Robotic-assisted laparoscopic prostatectomy: what is the learning curve?","volume":"66","author":"Herrell","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.10.005_bib31","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/jama.283.3.354","article-title":"Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes study","volume":"283","author":"Stanford","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2008.10.005_bib32","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0022-5347(01)65488-0","article-title":"Risk factors for urinary incontinence after radical prostatectomy","volume":"156","author":"Eastham","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib33","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0022-5347(05)67294-1","article-title":"Prospective assessment of patient reported urinary continence after radical prostatectomy","volume":"164","author":"Wei","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib34","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0090-4295(01)01008-1","article-title":"Rationale for and results of nerve grafting during radical prostatectomy","volume":"57","author":"Scardino","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.10.005_bib35","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1097\/01.ju.0000145222.94455.73","article-title":"Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies","volume":"172","author":"Kundu","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib36","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/01.ju.0000158163.21079.66","article-title":"Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters","volume":"173","author":"Bianco","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib37","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0360-3016(02)02829-8","article-title":"Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial","volume":"53","author":"Pollack","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2008.10.005_bib38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0360-3016(98)00091-1","article-title":"Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer","volume":"41","author":"Zelefsky","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2008.10.005_bib39","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-5347(05)65855-7","article-title":"High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer","volume":"166","author":"Zelefsky","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib40","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0360-3016(99)00498-8","article-title":"Dose selection for prostate cancer patients based on dose comparison and dose response studies","volume":"46","author":"Hanks","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2008.10.005_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0090-4295(99)00380-5","article-title":"Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate","volume":"55","author":"Lyons","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.10.005_bib42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0360-3016(03)00569-8","article-title":"Dose escalation for localized prostate cancer: substantial benefit observed with 3D conformal therapy","volume":"57","author":"Symon","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2008.10.005_bib43","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","article-title":"Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2008.10.005_bib44","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.2005.05.2530","article-title":"Dose\u2013response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy","volume":"24","author":"Peeters","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2008.10.005_bib45","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urology.2008.10.005_bib46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(02)09408-4","article-title":"Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial","volume":"360","author":"Bolla","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2008.10.005_bib47","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1200\/JCO.1997.15.3.1013","article-title":"Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group protocol 85-31","volume":"15","author":"Pilepich","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2008.10.005_bib48","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0360-3016(01)01579-6","article-title":"Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate","volume":"50","author":"Pilepich","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2008.10.005_bib49","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1200\/JCO.2003.11.023","article-title":"Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: Radiation Therapy Oncology Group protocol 92-02","volume":"21","author":"Hanks","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2008.10.005_bib50","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.292.7.821","article-title":"Six-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial","volume":"292","author":"D'Amico","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2008.10.005_bib51","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0360-3016(91)90732-J","article-title":"Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706","volume":"21","author":"Lawton","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2008.10.005_bib52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0167-8140(99)00100-0","article-title":"Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer","volume":"55","author":"Zelefsky","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.urology.2008.10.005_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0360-3016(97)00554-3","article-title":"Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer","volume":"40","author":"Zelefsky","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2008.10.005_bib54","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0090-4295(98)00594-9","article-title":"Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate","volume":"53","author":"Zelefsky","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.10.005_bib55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0090-4295(03)00133-X","article-title":"Efficacy of sildenafil in an open-label study as a continuation of a double-blind study in the treatment of erectile dysfunction after radiotherapy for prostate cancer","volume":"62","author":"Incrocci","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.10.005_bib56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0360-3016(01)01601-7","article-title":"Ten-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy","volume":"51","author":"Grimm","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2008.10.005_bib57","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0360-3016(03)00627-8","article-title":"Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality","volume":"57","author":"Kollmeier","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2008.10.005_bib58","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0090-4295(01)01233-X","article-title":"Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer","volume":"58","author":"Kattan","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.10.005_bib59","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.ijrobp.2005.07.062","article-title":"Long-term multi-institutional analysis of stage T1\u2013T2 prostate cancer treated with permanent brachytherapy","volume":"63","author":"Zelefsky","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2008.10.005_bib60","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/01.ju.0000154633.73092.8e","article-title":"Twelve-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer","volume":"173","author":"Potters","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib61","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2630::AID-CNCR20>3.3.CO;2-C","article-title":"The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy","volume":"85","author":"Davis","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2008.10.005_bib62","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0360-3016(01)02658-X","article-title":"Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation","volume":"52","author":"Crook","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2008.10.005_bib63","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0022-5347(01)62542-4","article-title":"Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate","volume":"160","author":"Terk","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib64","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0889-8588(05)70359-2","article-title":"Does brachytherapy have a role in the treatment of prostate cancer?","volume":"10","author":"Grimm","year":"1996","journal-title":"Hematol\/Oncol Clin North Am"},{"key":"10.1016\/j.urology.2008.10.005_bib65","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0360-3016(02)04142-1","article-title":"Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy","volume":"55","author":"Zelefsky","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2008.10.005_bib66","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0360-3016(01)02675-X","article-title":"Erectile function after permanent prostate brachytherapy","volume":"52","author":"Merrick","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2008.10.005_bib67","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0360-3016(00)00632-5","article-title":"Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer","volume":"48","author":"Gelblum","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2008.10.005_bib68","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/01.ju.0000095025.03331.c6","article-title":"Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE)","volume":"170","author":"Cooperberg","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib69","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1016\/j.urology.2008.10.005_bib70","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1200\/jco.2005.23.16_suppl.4625","article-title":"Primary androgen deprivation therapy in localized disease: predictors of definitive treatment: American Society of Clinical Oncology (ASCO) Annual Meeting Proceedings","volume":"23","author":"Kawakami","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2008.10.005_bib71","first-page":"217","article-title":"Long-term combined androgen blockade alone for localized prostate cancer","volume":"3","author":"Labrie","year":"1999","journal-title":"Mol Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib72","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0090-4295(02)01639-4","article-title":"Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer?","volume":"60","author":"Labrie","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.10.005_bib73","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/jjco\/hyh061","article-title":"Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP surveillance","volume":"34","author":"Akaza","year":"2004","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.urology.2008.10.005_bib74","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1634\/theoncologist.6-2-177","article-title":"Treatment of localized prostate cancer with intermittent triple androgen blockade: preliminary results in 110 consecutive patients","volume":"6","author":"Leibowitz","year":"2001","journal-title":"Oncologist"},{"key":"10.1016\/j.urology.2008.10.005_bib75","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/1097-0142(19930501)71:9<2782::AID-CNCR2820710916>3.0.CO;2-Z","article-title":"Effects of intermittent androgen suppression on androgen-dependent tumors: apoptosis and serum prostate-specific antigen","volume":"71","author":"Akakura","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2008.10.005_bib76","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0090-4295(96)00381-0","article-title":"Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study","volume":"48","author":"Higano","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.10.005_bib77","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0090-4295(97)00488-3","article-title":"Intermittent androgen deprivation for clinically localized prostate cancer: initial experience","volume":"51","author":"Grossfeld","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.10.005_bib78","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0090-4295(98)00547-0","article-title":"Intermittent androgen suppression in the management of prostate cancer","volume":"53","author":"Crook","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.10.005_bib79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1634\/theoncologist.5-1-45","article-title":"Intermittent androgen deprivation in prostate cancer patients: factors predictive of prolonged time off therapy","volume":"5","author":"Strum","year":"2000","journal-title":"Oncologist"},{"key":"10.1016\/j.urology.2008.10.005_bib80","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0090-4295(96)00048-9","article-title":"Low-dose cyproterone acetate plus mini-dose diethylstilbestrol\u2014a protocol for reversible medical castration","volume":"47","author":"Goldenberg","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.10.005_bib81","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/01.ju.0000139719.99825.54","article-title":"Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6","volume":"172","author":"Iversen","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.10.005_bib82","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/cncr.20388","article-title":"Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy","volume":"101","author":"Krupski","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2008.10.005_bib83","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/cncr.20955","article-title":"Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma","volume":"103","author":"Shahinian","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2008.10.005_bib84","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1200\/JCO.2006.09.3369","article-title":"Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions","volume":"25","author":"D'Amico","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2008.10.005_bib85","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/jnci\/djm168","article-title":"Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality","volume":"99","author":"Tsai","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2008.10.005_bib86","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/cncr.22933","article-title":"Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer","volume":"110","author":"Saigal","year":"2007","journal-title":"Cancer"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429508017330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429508017330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T11:09:01Z","timestamp":1558004941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429508017330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0090429508017330"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2008.10.005","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}